Dr. Robert M. Reinauer Jr., MD

Dr. Reinauer practices at New Vision Surgical Center - Vero Beach in Vero Beach, Florida.

Dr. Reinauer's NPI, 1972839983, was assigned on October 26, 2009. Dr. Reinauer graduated from Joe R. & Teresa Lozano Long School of Medicine in 2009. Dr. Reinauer's Texas license number on file is P6253.

Dr. Reinauer's primary practice is New Vision Surgical Center - Vero Beach, at 1055 37th Place, Vero Beach, FL 32960. The practice phone is (772) 257-8700.

Dr. Reinauer's primary practice is New Vision Surgical Center - Vero Beach in Vero Beach, Florida. Dr. Reinauer is also affiliated with Cleveland Clinic Indian River Hospital. Dmand AI also links Dr. Reinauer to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reinauer practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Reinauer's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Reinauer is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Reinauer's licenses on file in 3 states: Texas, Florida and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Reinauer treats.

CMS data shows 1,311,454 Medicare services from Dr. Reinauer across 31 procedure codes in 2024, for 2,130 Medicare patients. Medicare paid $9,861,697 for them.

CMS counts 2,130 Medicare patients who saw Dr. Reinauer in 2024. The largest group is 75 to 84, with 928 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reinauer's median patient age at 77, with 56% women.

In 2024, Dr. Reinauer wrote 1,734 Medicare Part D claims for 447 patients. 65% of them were for generic drugs. CMS names the drug for 1,660 of them, across 16 drugs with 11 or more claims each, at $78,456 in total drug cost. In 2023, CMS named 2,043 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Reinauer for performance year 2024, reported as part of a group. Dr. Reinauer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of cataract surgery by Dr. Reinauer, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Reinauer in 2025. 2025 was the busiest year, with 2. Dr. Reinauer has published most often in Clin Ophthalmol. Dr. Reinauer's most frequent co-authors are Ryan Bradford Rush, MD, Sloan Whitmore Rush, MD and David Judson Browning, MD, PhD.

CMS Open Payments shows 93 general payments to Dr. Reinauer from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $935.

Dr. Reinauer graduated from Joe R. & Teresa Lozano Long School of Medicine in 2009.

Dr. Reinauer is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.